EIF2AK3 and neuroblastoma: Another study found that treatment with Aβ triggered the UPR in SK-N-SH human neuroblastoma cells, and selective activation of the PERK pathway using Salubrinal prevented Aβ-induced toxicity (Lee et al., 2010a).